Mirae Asset Global Investments’s Varian Medical Systems, Inc. VAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-7,703
Closed -$1.35M 1679
2020
Q4
$1.35M Sell
7,703
-20,751
-73% -$3.6M 0.01% 1054
2020
Q3
$4.89M Buy
28,454
+1,512
+6% +$238K 0.02% 558
2020
Q2
$3.3M Buy
26,942
+5,967
+28% +$691K 0.02% 583
2020
Q1
$2.15M Buy
20,975
+1,406
+7% +$186K 0.02% 629
2019
Q4
$2.78M Sell
19,569
-9,079
-32% -$1.16M 0.02% 653
2019
Q3
$3.41M Sell
28,648
-2,929
-9% -$348K 0.02% 567
2019
Q2
$4.3M Buy
31,577
+258
+0.8% +$34.5K 0.03% 499
2019
Q1
$4.44M Buy
31,319
+5,091
+19% +$669K 0.03% 437
2018
Q4
$2.97M Sell
26,228
-855
-3% -$97.8K 0.03% 504
2018
Q3
$3.03M Buy
27,083
+10,027
+59% +$1.13M 0.02% 542
2018
Q2
$1.94M Buy
17,056
+2,299
+16% +$275K 0.03% 375
2018
Q1
$1.81M Buy
14,757
+2,457
+20% +$293K 0.02% 392
2017
Q4
$1.37M Buy
+12,300
New +$1.32M 0.02% 418

Other funds holding VAR

Mirae Asset Global Investments's VAR Position: Q1 2021 in Review

Mirae Asset Global Investments sold out of Varian Medical Systems, Inc. (VAR) in Q1 2021, closing a stake of 7,703 shares — an estimated $1.35M sold.

Mirae Asset Global Investments first reported a position in VAR in Q4 2017 and held it in 13 quarters. The position peaked at $4.89M in Q3 2020. 600 funds tracked by Wall St. Rank hold VAR as of Q1 2021.

  • Mirae Asset Global Investments reported no remaining Varian Medical Systems, Inc. position as of Q1 2021 after selling out during the quarter.
  • Mirae Asset Global Investments sold 7,703 Varian Medical Systems, Inc. shares in Q1 2021, an estimated $1.35M.
  • Mirae Asset Global Investments first reported a position in Varian Medical Systems, Inc. in Q4 2017 and held it in 13 quarters.
  • Mirae Asset Global Investments's Varian Medical Systems, Inc. position peaked at $4.89M in Q3 2020.
  • 600 funds tracked by Wall St. Rank held Varian Medical Systems, Inc. as of Q1 2021.

Based on Mirae Asset Global Investments's 13F filing for Q1 2021, filed 13 May 2021.